Le Lézard
Classified in: Health, Science and technology
Subject: SVY

Nucleic Acid Isolation & Purification Market Worth $3.6 Billion by 2025: Grand View Research, Inc.


SAN FRANCISCO, December 10, 2018 /PRNewswire/ --

The global nucleic acid isolation & purification market size is expected to reach USD 3.6 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 6.8% during the forecast period. Decreasing cost of genetic sequencing, ongoing developments in genetics, personalized medicine, and diagnostics, and increasing automation and technological advancements in instruments and tools used for isolation and purification of polynucleotides are some of the key factors driving this market.

     (Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg )

Nucleic acid isolation and purification is the most basic step deployed in any biological research. Extraction, isolation, and purification of DNA and RNA are very crucial and need the help of experts. These techniques are mostly used in cloning, sequencing, genetic engineering, life science research, forensics, agriculture, and other fields.

Utilization of nucleic acids has gone beyond mere storage of genetic information and protein synthesis. These biological moieties can be used in myriad healthcare domains such as gene therapy, therapeutics and diagnostics, precision medicine, and forensics.

Over the years, scientists have been able to separate and purify nucleic moieties such as mRNA, miRNA, plasmid DNA, and genomic DNA. This is helpful in studying diseases and their pathologies at a genetic level in detail, which in turn, has proved helpful in designing therapeutics and diagnostics for several life threatening diseases. The detachment, disengagement, ligation, and purification of nucleic acids has become a lot easier than before, thanks to technological advancements and increasing use of DNA/RNA sequencing.

Various methods are used for the isolation and purification of nucleic acids such as silica based, magnetic bead based, and reagent based. Magnetic bead-based isolation and purification has become increasingly popular among researchers. These techniques and tools are utilized by diagnostic labs and clinics, pharmaceutical and biotech companies, scholastic research institutes, and hospitals.

North America currently holds the largest share in this market, followed by Europe. Asia is likely to register the fastest growth owing to its rapidly expanding economy, rising healthcare expenditure, and increasing government financing in research projects.

High cost of instruments that are utilized as part of the methodology for isolation and purification of nucleic acids is one of the key challenges in the market, especially in emerging countries. Major players in this market include QIAGEN; Danaher Corporation; Thermo Fisher Scientific, Inc.; Agilent Technologies Inc.; Bio-Rad Laboratories Inc.; and Promega Corporation.

Browse full research report with TOC on "Nucleic Acid Isolation and Purification Market Analysis Report By Product, By Type (DNA, RNA), By Application (Drug Discovery, Oncology), By Method, By End Use, By Region, And Segment Forecasts, 2018 - 2025" at: https://www.grandviewresearch.com/industry-analysis/nucleic-acid-solation-and-purification-market

Further Key Findings From the Report Suggest: 

Browse related reports by Grand View Research: 

Grand View Research has segmented the global nucleic acid isolation & purification market based on product, type, application, method, end use, and region: 

Explore the BI enabled intuitive market research database, Grand View Compass, by Grand View Research, Inc.

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]

Web: https://www.grandviewresearch.com

SOURCE Grand View Research, Inc.


These press releases may also interest you

at 05:25
PureTech Health plc ("PureTech" or the "Company") today announces its results for the year ended December 31, 2023, as well as its cash balance as of the first quarter ended March 31, 2024. The following information represents select highlights from...

at 05:11
Hyundai Bioscience announced on April 25th that its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cancer caused by p53 gene mutations. Mutations in the p53 gene occur in almost...

at 04:31
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CHINA, HONG KONG, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR...

at 04:30
The Balance RehabClinic, renowned for its luxury mental health and addiction services, proudly announces its expansion into The Balance Healthcare Group: a collection of premium mental health solutions tailored for affluent individuals. These new...

at 03:47
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...



News published on and distributed by: